RA Capital Nexus Fund, L.P. Sells Shares of Vor Biopharma Inc.

RA Capital Nexus Fund, L.P., a significant stockholder and director of Vor Biopharma Inc., has filed a Form 144 indicating its intention to sell shares of the company. The filing details the sale of 15,104 common shares with an aggregate market value of $444,510.72, scheduled for October 20, 2025. Additionally, the fund has reported recent sales of 84,162 common shares over the past three months, totaling $2,240,083.66 in gross proceeds. The shares were acquired through private financing transactions between June 2020 and February 2021. The filing highlights the fund's ongoing divestment from Vor Biopharma, which could impact the company's stock price and investor sentiment.